Table 5 The characteristics of patients after 4 weeks follow-up
Variables | Group I (n = 41) | Group II(n = 67) | Group III(n = 26) | P-value |
|---|---|---|---|---|
BMRC stage (n, %) | 0.073 | |||
 1 | 17(41.5%) | 12(17.9%) | 5(19.2%) | |
 2 | 23(56.1%) | 52(77.6%) | 20(76.9%) | |
 3 | 1(2.4%) | 3(4.5%) | 1(3.8%) | |
Number of lumbar punctures within 4 weeks, median (IQR) | 5(3.5–5.5) | 5(4–6) | 5(4–5) | 0.808 |
CSF opening pressure, median (IQR), mmH2O | 162.5(119–211.25) | 210(145–260) | 240(170–230) | 0.006* |
CSF cryptococci, median (IQR), count/ml | 38.5(0–179.5) | 1(0–357) | 3(0–56) | 0.518 |
CSF clearance | ||||
Case (n, %) | 25(61.0%) | 36(53.7%) | 7(26.9%) | 0.02* |
CSF white blood cell, median (IQR), *10^6/l | 43.5(18.5–78.25) | 50(22–86) | 64(16–90) | 0.734 |
CSF protein, median (IQR), g/l | 0.97(0.40–1.36) | 0.80(0.47–2.27) | 0.87(0.42–1.06) | 0.446 |
CSF glucose, median (IQR), g/l | 2.25(0.87–3.55) | 2.12(1.06–2.64) | 2.38(1.76–2.71) | 0.456 |
CSF chloride, median (IQR), mmol/l | 122.3(117.4–124.73) | 120.8(117.1–123) | 122.1(117.1–124.9) | 0.395 |